1-8 of 8
Martin Chandler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD

Robert F. Sidonio, Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Haduwa Momoh, Priscilla Driscoll-Shempp, Bethany Jones, Natalia Nieto, Jorge Caicedo
Journal: Blood
Blood (2023) 142 (Supplement 1): 2613.
https://doi.org/10.1182/blood-2023-174729
Published: 2023
Journal Articles

Real-World Data on Hemophilia a Patients Transitioning from Bay 81-8973 to Bay 94-9027 and from Bay 14-2222 to Bay 81-8973 and then to Bay 94-9027 in the Athndataset

Martin Chandler, Jessica Charlet, Thomas Moulton, Michael Recht
Journal: Blood
Blood (2023) 142 (Supplement 1): 5479.
https://doi.org/10.1182/blood-2023-188995
Published: 2023
Journal Articles

Risk of Intracranial Hemorrhage in US Patients with Hemophilia a: Real-World Retrospective Cohort Study Using the Athndataset

Brian Hu, Martin Chandler, Matthew Manuel, Jorge Caicedo, Michael Denne, Bruce Ewenstein, Ali Mokdad, Shan Xing, Michael Recht
Journal: Blood
Blood (2022) 140 (Supplement 1): 2722–2723.
https://doi.org/10.1182/blood-2022-163861
Published: 2022
Journal Articles

Real-World Use of Octocog Alfa and Damoctocog Alfa Pegol in Women with Hemophilia a from the ATHNdataset

Martin Chandler, Jessica Charlet, Thomas Moulton, Michael Recht
Journal: Blood
Blood (2022) 140 (Supplement 1): 2751–2752.
https://doi.org/10.1182/blood-2022-166669
Published: 2022
Journal Articles

Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Michael Recht, Robert F. Sidonio, Jr.
Journal: Blood
Blood (2022) 140 (Supplement 1): 5600–5602.
https://doi.org/10.1182/blood-2022-163302
Published: 2022
Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Inhibitor Development and Treatment Characteristics

Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F. Sidonio, Jr., Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D. Thornburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 63–64.
https://doi.org/10.1182/blood-2022-162660
Published: 2022
Journal Articles

Real-World Effectiveness of Damoctocog Alfa Pegol in the Subgroup of Adolescent Hemophilia A Patients Aged 12-18 Years in the ATHNdataset

Martin Chandler, Michael Recht, Chunla He, Thomas Moulton, Lena Charafi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4241.
https://doi.org/10.1182/blood-2021-152345
Published: 2021
Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Kenneth D. Friedman, Sweta Gupta, Kristina M. Haley, Chunla He, Nikki Hirsh, Salley Pels, Jonathan C. Roberts, Tung T. Wynn, Robert F. Sidonio, Jr.
Journal: Blood
Blood (2021) 138 (Supplement 1): 3183.
https://doi.org/10.1182/blood-2021-145631
Published: 2021